Johnson Financial Group Inc. raised its position in Clorox Company (The) (NYSE:CLX) by 4.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,348 shares of the company’s stock after buying an additional 168 shares during the period. Johnson Financial Group Inc.’s holdings in Clorox Company (The) were worth $586,000 as of its most recent filing with the SEC.

A number of other hedge funds have also modified their holdings of CLX. Quadrant Capital Group LLC increased its stake in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock worth $106,000 after buying an additional 158 shares during the last quarter. Valley National Advisers Inc. boosted its position in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Welch Group LLC boosted its position in Clorox Company (The) by 3.5% in the first quarter. Welch Group LLC now owns 1,057 shares of the company’s stock worth $143,000 after buying an additional 36 shares during the period. Finally, Pinnacle Bank bought a new position in Clorox Company (The) during the first quarter worth about $148,000. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (NYSE CLX) traded up 0.75% on Monday, reaching $135.50. 584,768 shares of the company were exchanged. The firm has a 50-day moving average of $134.79 and a 200 day moving average of $133.07. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The firm has a market capitalization of $17.45 billion, a P/E ratio of 26.77 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter last year, the business earned $1.30 earnings per share. Clorox Company (The)’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities analysts predict that Clorox Company will post $5.68 earnings per share for the current year.

WARNING: This story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/08/07/clorox-company-the-nyseclx-stake-increased-by-johnson-financial-group-inc-updated-updated-updated.html.

A number of research firms have recently issued reports on CLX. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub cut shares of Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Barclays PLC dropped their price target on shares of Clorox Company (The) from $140.00 to $136.00 and set an “equal weight” rating on the stock in a research report on Friday. Finally, BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the stock a “buy” rating in a research report on Thursday. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.